{"entity":{"type":"insider","cik":"0001594935","url":"/insider/0001594935","json_url":"/insider/0001594935.json","name":"SMITH LAWRENCE RUSSELL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":16,"first":"2014-01-14","last":"2017-03-17","span_basis":"filed_date"},"name_variants":[{"name":"SMITH LAWRENCE RUSSELL","source":"filing","n_filings":16,"first_seen":"2014-01-14","last_seen":"2017-03-17"}],"transactions":[{"id":4987566,"accession":"0001209191-17-021409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021409","line_url":"/filing/0001209191-17-021409#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":2021.25,"total_display":"2,021.25","total_whole":"2,021","shares_owned_after":17696.0,"shares_owned_after_display":"17,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-17","scope":"insider"},{"id":5155710,"accession":"0001209191-17-010455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-010455","line_url":"/filing/0001209191-17-010455#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":2.2578,"price_display":"2.26","price_state":"stated","total_value":10160.1,"total_display":"10,160.10","total_whole":"10,160","shares_owned_after":18571.0,"shares_owned_after_display":"18,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-10","filed_date":"2017-02-14","scope":"insider"},{"id":5278015,"accession":"0001209191-17-003663","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-003663","line_url":"/filing/0001209191-17-003663#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54.0,"shares_display":"54","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":133.92,"total_display":"133.92","total_whole":"134","shares_owned_after":23071.0,"shares_owned_after_display":"23,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-11","filed_date":"2017-01-13","scope":"insider"},{"id":3086485,"accession":"0001209191-16-145680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-145680","line_url":"/filing/0001209191-16-145680#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54.0,"shares_display":"54","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":164.7,"total_display":"164.70","total_whole":"165","shares_owned_after":23125.0,"shares_owned_after_display":"23,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-11","filed_date":"2016-10-12","scope":"insider"},{"id":2319344,"accession":"0001209191-16-132504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-132504","line_url":"/filing/0001209191-16-132504#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54.0,"shares_display":"54","price_per_share":4.46,"price_display":"4.46","price_state":"stated","total_value":240.84,"total_display":"240.84","total_whole":"241","shares_owned_after":23179.0,"shares_owned_after_display":"23,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-11","filed_date":"2016-07-13","scope":"insider"},{"id":3290858,"accession":"0001209191-16-109098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-109098","line_url":"/filing/0001209191-16-109098#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":0.4095,"price_display":"0.41","price_state":"stated","total_value":3583.125,"total_display":"3,583.12","total_whole":"3,583","shares_owned_after":232331.0,"shares_owned_after_display":"232,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-15","filed_date":"2016-03-17","scope":"insider"},{"id":3118030,"accession":"0001209191-16-091132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-091132","line_url":"/filing/0001209191-16-091132#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":0.36,"price_display":"0.36","price_state":"stated","total_value":350.64,"total_display":"350.64","total_whole":"351","shares_owned_after":241081.0,"shares_owned_after_display":"241,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-13","scope":"insider"},{"id":8084183,"accession":"0001209191-15-075381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-075381","line_url":"/filing/0001209191-15-075381#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":0.426,"price_display":"0.43","price_state":"stated","total_value":414.924,"total_display":"414.92","total_whole":"415","shares_owned_after":242055.0,"shares_owned_after_display":"242,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-12","filed_date":"2015-10-14","scope":"insider"},{"id":8886163,"accession":"0001209191-15-060946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-060946","line_url":"/filing/0001209191-15-060946#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":0.6983,"price_display":"0.70","price_state":"stated","total_value":680.1442,"total_display":"680.14","total_whole":"680","shares_owned_after":243029.0,"shares_owned_after_display":"243,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-13","filed_date":"2015-07-15","scope":"insider"},{"id":8489055,"accession":"0001209191-15-034286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-034286","line_url":"/filing/0001209191-15-034286#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":0.9335,"price_display":"0.93","price_state":"stated","total_value":909.229,"total_display":"909.23","total_whole":"909","shares_owned_after":244003.0,"shares_owned_after_display":"244,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-13","filed_date":"2015-04-15","scope":"insider"},{"id":8659944,"accession":"0001209191-15-004136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-004136","line_url":"/filing/0001209191-15-004136#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912.0,"shares_display":"1,912","price_per_share":1.1557,"price_display":"1.16","price_state":"stated","total_value":2209.6984,"total_display":"2,209.70","total_whole":"2,210","shares_owned_after":174977.0,"shares_owned_after_display":"174,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-14","scope":"insider"},{"id":6322763,"accession":"0001209191-14-063135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-063135","line_url":"/filing/0001209191-14-063135#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912.0,"shares_display":"1,912","price_per_share":1.0812,"price_display":"1.08","price_state":"stated","total_value":2067.2544,"total_display":"2,067.25","total_whole":"2,067","shares_owned_after":176889.0,"shares_owned_after_display":"176,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-13","filed_date":"2014-10-14","scope":"insider"},{"id":6184971,"accession":"0001181431-14-030244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-030244","line_url":"/filing/0001181431-14-030244#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.2539,"price_display":"1.25","price_state":"stated","total_value":15673.75,"total_display":"15,673.75","total_whole":"15,674","shares_owned_after":178801.0,"shares_owned_after_display":"178,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-26","filed_date":"2014-08-27","scope":"insider"},{"id":6553815,"accession":"0001181431-14-026679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-026679","line_url":"/filing/0001181431-14-026679#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912.0,"shares_display":"1,912","price_per_share":1.1639,"price_display":"1.16","price_state":"stated","total_value":2225.3768,"total_display":"2,225.38","total_whole":"2,225","shares_owned_after":191301.0,"shares_owned_after_display":"191,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-11","filed_date":"2014-07-15","scope":"insider"},{"id":6781558,"accession":"0001181431-14-016126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-016126","line_url":"/filing/0001181431-14-016126#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912.0,"shares_display":"1,912","price_per_share":1.2054,"price_display":"1.21","price_state":"stated","total_value":2304.7248,"total_display":"2,304.72","total_whole":"2,305","shares_owned_after":193213.0,"shares_owned_after_display":"193,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-11","filed_date":"2014-04-14","scope":"insider"},{"id":6304263,"accession":"0001181431-14-002328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-002328","line_url":"/filing/0001181431-14-002328#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001594935","owner_name":"SMITH LAWRENCE RUSSELL","owner_display_name":"SMITH LAWRENCE RUSSELL","owner_url":"/insider/0001594935","role":"Officer (VP, Vaccine Research)","role_mark":"O","role_mark_label":"Officer (VP, Vaccine Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Vaccine Research","security_title":"Common Stock $.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":127800.0,"total_display":"127,800.00","total_whole":"127,800","shares_owned_after":197422.0,"shares_owned_after_display":"197,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-10","filed_date":"2014-01-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000819050","name":"VICAL INC","url":"/issuer/0000819050","role":"Officer (VP, Vaccine Research)","n_filings":16,"first_seen":"2014-01-14","last_seen":"2017-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001594935","retrieved_at":"2026-08-25T15:01:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}